TICAROS
Ticaros is a biotech company that develops immune anti-cancer drugs.
TICAROS
Industry:
Biotechnology Clinical Trials Pharmaceutical Therapeutics
Founded:
2008-01-01
Address:
Seongdong, Kyonggi-do, South Korea
Country:
South Korea
Website Url:
http://www.ticaros.com
Total Employee:
1+
Status:
Active
Contact:
+82 02 745 6655
Email Addresses:
[email protected]
Total Funding:
31.1 B KRW
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail ASP.NET IIS IIS 10 Sectigo SSL Sectigo Domain SSL Classic ASP SK Broadband
Similar Organizations
Accelerated Pharma
Accelerated Pharma is a biotechnology company that develops treatment for cancer.
Astrogen
Astrogen is a biotech company developing new drugs.
Autotelic Bio
Autotelic Bio is a bio technology company that researches and develops anti-cancer drugs.
BiVictriX Therapeutics
Biotech focused on developing novel, highly-selective, bispecific ADCs to target unmet need in blood cancer.
GenEros Biopharma
GenEros Biopharma is a biopharmaceutical company that develops autoimmune and anti-inflammation therapeutics.
HankeMab
HankeMab is a biotechnology company that develops antibody drugs.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Yipscell
Yipscell is a biotech company that develops IPSC stem cell therapy to diagnose and treat incurable diseases.
Investors List
Shinhan Venture Investment
Shinhan Venture Investment investment in Series C - Ticaros
Daesung Private Equity
Daesung Private Equity investment in Series C - Ticaros
Kingo Investment Partners
Kingo Investment Partners investment in Series C - Ticaros
KOSME
KOSME investment in Series C - Ticaros
Woori Financial Group
Woori Financial Group investment in Series C - Ticaros
UTC Investment Co.
UTC Investment Co. investment in Series C - Ticaros
Posco
Posco investment in Series C - Ticaros
HG Initiative
HG Initiative investment in Series C - Ticaros
Medici Investment
Medici Investment investment in Series C - Ticaros
Medytox Venture Investment
Medytox Venture Investment investment in Series B - Ticaros
More informations about "Ticaros"
TICAROS
TiCARos proposes a new treatment option using cutting-edge technology in immunology and antibody-engineering We develop best-in class, first-in class therapies based on Converter CAR platform for better T cell activity and on …See details»
TICAROS
TiCARos Co.Ltd is a biotech company which develops the next generation immunotherapeutics for cancers. Recently, alongside with antibody techniques, the immuno-oncology therapies are …See details»
Ticaros - Crunchbase Company Profile & Funding
Organization. Ticaros . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Ticaros is a biotech …See details»
Ticaros 2025 Company Profile: Valuation, Funding
Ticaros General Information Description. Developer of CAR-T cell therapy intended to treat patients with relapsed and refractory cancer. The company's …See details»
Ticaros - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Sep 24, 2021: Series C - …See details»
TiCARos tapped as J&J Innovation-supported JLABS company
Jul 31, 2024 TiCARos, a developer of CAR-T therapies, said it has recently been selected to join JLABS, a global accelerator platform operated by pharmaceutical company Johnson & …See details»
Ticaros Co., Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Ticaros Co., Ltd. with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Neoplasms, Immune System Diseases, Hemic and Lymphatic Diseases, Technology …See details»
Ticaros - Crunchbase
Ticaros is a biotech company that develops immune anti-cancer drugs.See details»
TiCARos - BIO KOREA
TiCARos develops matchless CAR-T and cell therapeutics for cancer treatment, by leveraging accumulated experiences and technologies of the immunologists at Seoul National University, …See details»
TiCARos - Products, Competitors, Financials, Employees, …
TiCARos engineered antigens such as CD19 and CD40 that target cancer cells to express specific epitopes, and uses CAR-T cells that bind to these epitopes. As a result, they bind in …See details»
TICAROS
Thus, TiCARos setup a system in which CAR-T cells can be produced in a more reproducible and a safer way. Company Introduction; Location; Contact Us; TiCARos Co.Ltd. Address : Room 1101-1106 11th Floor, Seongsoo AK valley, …See details»
티카로스
TiCARos. OVERVIEW OF THE COMPANY. Next Generation. Immunotherapy ㈜티카로스는 차세대 면역 항암제를 개발하는 바이오텍입니다. 최근 면역 항암치료제는 항체 기술과 더불어 …See details»
TiCARos - BIO International Convention | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... TiCARos is developing very …See details»
“Creating Paradigm Shift for Current CAR T Landscape” - 한경닷컴
TiCARos, Inc., a Korean biotech, established in 2018 by distinguished experts from industry and academia, to develop next-generation Immunotherapeutics for Complete Cure of intractable …See details»
TiCARos' Converter and CLIP CAR Technologies-Enhancing CAR-T …
Feb 3, 2022 TiCARos' proprietary CAR-T platform technologies explained. Learn more at Ticaros.com*The video has been produced by life-science-animation.comSee details»
Cartherics enters into Collaborative Research Agreement with …
Melbourne, Australia, 2 April 2024 – Cartherics Pty Ltd (“Cartherics”), a biotechnology company developing immune cell therapies for the treatment of cancer, is pleased to announce that it …See details»
Ticaros - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Jan 13, 2025 Ticaros is a biotech company that develops immune anti-cancer drugs.See details»
临床Ⅰ/Ⅱ期同时获批IND | 药明生基首个赋能的韩国细胞治疗项 …
TICAROS首席执行官Jae Won Lee 先生表示：“非常感谢药明生基在我们下一代CAR-T 细胞疗法中开发中所做的工作，先后与药明生基在英国、中国等全球化基地的合作，大大提升了我们的药 …See details»
An End-to-End Solution to Accelerate CAR-T Cell Development …
And advanced solid tumours. TiCARos’ mission is to create medication based on science. TiCARos was founded by two leading T-cell immunologists, who have built a team with a deep …See details»
TICAROS
TiCARos Co.Ltd Address : Room 1101-1106 11th Floor, Seongsoo AK valley, 76, Yeonmujang-gil, Seongdong-gu, Seoul, Republic of Korea TEL : 02-745-6655 FAX : 02-745-6656 CEO : …See details»